BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 31050815)

  • 21. Increased Cardiovascular Risk in Patients with Adrenal Insufficiency: A Short Review.
    Rahvar AH; Haas CS; Danneberg S; Harbeck B
    Biomed Res Int; 2017; 2017():3691913. PubMed ID: 29376070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The impact of different glucocorticoid replacement schedules on bone turnover and insulin sensitivity in patients with adrenal insufficiency.
    Suliman AM; Freaney R; Smith TP; McBrinn Y; Murray B; McKenna TJ
    Clin Endocrinol (Oxf); 2003 Sep; 59(3):380-7. PubMed ID: 12919163
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Standardised patient education in adrenal insufficiency: a prospective multi-centre evaluation.
    Burger-Stritt S; Eff A; Quinkler M; Kienitz T; Stamm B; Willenberg HS; Meyer G; Klein J; Reisch N; Droste M; Hahner S
    Eur J Endocrinol; 2020 Aug; 183(2):119-127. PubMed ID: 32580144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Unmet Needs in the Treatment of Adrenal Crisis: Importance of the Patient's Perspective.
    Claessen KMJA; Andela CD; Biermasz NR; Pereira AM
    Front Endocrinol (Lausanne); 2021; 12():701365. PubMed ID: 34354671
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of adrenal insufficiency in different clinical settings.
    Hahner S; Allolio B
    Expert Opin Pharmacother; 2005 Nov; 6(14):2407-17. PubMed ID: 16259572
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial.
    Isidori AM; Venneri MA; Graziadio C; Simeoli C; Fiore D; Hasenmajer V; Sbardella E; Gianfrilli D; Pozza C; Pasqualetti P; Morrone S; Santoni A; Naro F; Colao A; Pivonello R; Lenzi A
    Lancet Diabetes Endocrinol; 2018 Mar; 6(3):173-185. PubMed ID: 29229498
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term safety of once-daily, dual-release hydrocortisone in patients with adrenal insufficiency: a phase 3b, open-label, extension study.
    Nilsson AG; Bergthorsdottir R; Burman P; Dahlqvist P; Ekman B; Engström BE; Ragnarsson O; Skrtic S; Wahlberg J; Achenbach H; Uddin S; Marelli C; Johannsson G
    Eur J Endocrinol; 2017 Jun; 176(6):715-725. PubMed ID: 28292927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Replacement therapy of oral hydrocortisone in adrenal insufficiency: the influence of gastrointestinal factors.
    Lennernäs H; Skrtic S; Johannsson G
    Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):749-58. PubMed ID: 18611115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mortality Risk in Patients With Adrenal Insufficiency Using Prednisolone or Hydrocortisone: A Retrospective Cohort Study.
    Ngaosuwan K; Johnston DG; Godsland IF; Cox J; Majeed A; Quint JK; Oliver N; Robinson S
    J Clin Endocrinol Metab; 2021 Jul; 106(8):2242-2251. PubMed ID: 33993277
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Towards the tailoring of glucocorticoid replacement in adrenal insufficiency: the Italian Society of Endocrinology Expert Opinion.
    Isidori AM; Arnaldi G; Boscaro M; Falorni A; Giordano C; Giordano R; Pivonello R; Pozza C; Sbardella E; Simeoli C; Scaroni C; Lenzi A;
    J Endocrinol Invest; 2020 May; 43(5):683-696. PubMed ID: 31773582
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hair cortisol content in patients with adrenal insufficiency on hydrocortisone replacement therapy.
    Gow R; Koren G; Rieder M; Van Uum S
    Clin Endocrinol (Oxf); 2011 Jun; 74(6):687-93. PubMed ID: 21521272
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism.
    Watanabe T; Ozawa A; Ishii S; Tomaru T; Shibusawa N; Saito T; Yamada E; Horiguchi K; Nakajima Y; Matsumoto S; Yoshino S; Katano-Toki A; Hashimoto K; Mori M; Okada S; Satoh T; Yamada M
    Endocr J; 2018 May; 65(5):547-556. PubMed ID: 29618670
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy options for adrenal insufficiency and recommendations for the management of adrenal crisis.
    Nowotny H; Ahmed SF; Bensing S; Beun JG; Brösamle M; Chifu I; Claahsen van der Grinten H; Clemente M; Falhammar H; Hahner S; Husebye E; Kristensen J; Loli P; Lajic S; Reisch N;
    Endocrine; 2021 Mar; 71(3):586-594. PubMed ID: 33661460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Usefulness of Time-Point Serum Cortisol and ACTH Measurements for the Adjustment of Glucocorticoid Replacement in Adrenal Insufficiency.
    Rousseau E; Joubert M; Trzepla G; Parienti JJ; Freret T; Vanthygem MC; Desailloud R; Lefebvre H; Coquerel A; Reznik Y;
    PLoS One; 2015; 10(8):e0135975. PubMed ID: 26317782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emergency management of adrenal insufficiency in children: advocating for treatment options in outpatient and field settings.
    Miller BS; Spencer SP; Geffner ME; Gourgari E; Lahoti A; Kamboj MK; Stanley TL; Uli NK; Wicklow BA; Sarafoglou K
    J Investig Med; 2020 Jan; 68(1):16-25. PubMed ID: 30819831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors impacting on the action of glucocorticoids in patients receiving glucocorticoid therapy.
    Dineen R; Stewart PM; Sherlock M
    Clin Endocrinol (Oxf); 2019 Jan; 90(1):3-14. PubMed ID: 30120786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adrenal response to glucocorticoid treatment.
    Kasperlik-Saluska AA; Slowińska-Srzednicka J
    Lancet; 2000 Apr; 355(9213):1459. PubMed ID: 10791544
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of prednisolone during Ramadan fasting in patients with adrenal insufficiency.
    Hee NKY; Lim QH; Paramasivam S; Lim LL; Vethakkan S; Ganapathy SS; Ratnasingam J
    Clin Endocrinol (Oxf); 2024 Mar; 100(3):221-229. PubMed ID: 38031259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Management of Acute Adrenal Insufficiency-Related Adverse Events in Children with Congenital Adrenal Hyperplasia: Results of an International Survey of Specialist Centres.
    Ali SR; Bryce J; Krone NP; Claahsen-van der Grinten HL; Ahmed SF
    Horm Res Paediatr; 2022; 95(4):363-373. PubMed ID: 35569445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of Adrenal Crisis: Cortisol Responses to Major Stress Compared to Stress Dose Hydrocortisone Delivery.
    Prete A; Taylor AE; Bancos I; Smith DJ; Foster MA; Kohler S; Fazal-Sanderson V; Komninos J; O'Neil DM; Vassiliadi DA; Mowatt CJ; Mihai R; Fallowfield JL; Annane D; Lord JM; Keevil BG; Wass JAH; Karavitaki N; Arlt W
    J Clin Endocrinol Metab; 2020 Jul; 105(7):2262-74. PubMed ID: 32170323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.